IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells

J Immunol. 2000 Nov 15;165(10):5814-21. doi: 10.4049/jimmunol.165.10.5814.

Abstract

IL-17 is a newly discovered cytokine implicated in the regulation of hemopoiesis and inflammation. Because IL-17 production is restricted to activated T lymphocytes, the effects exerted by IL-17 may help one to understand the contribution of T cells to the inflammatory response. We investigated the role of IL-17 in leukocyte recruitment into the peritoneal cavity. Leukocyte infiltration in vivo was assessed in BALB/Cj mice. Effects of IL-17 on chemokine generation in vitro were examined in human peritoneal mesothelial cells (HPMC). Administration of IL-17 i.p. resulted in a selective recruitment of neutrophils into the peritoneum and increased levels of KC chemokine (murine homologue of human growth-related oncogene alpha (GROalpha). Pretreatment with anti-KC Ab significantly reduced the IL-17-driven neutrophil accumulation. Primary cultures of HPMC expressed IL-17 receptor mRNA. Exposure of HPMC to IL-17 led to a dose- and time-dependent induction of GROalpha mRNA and protein. Combination of IL-17 together with TNF-alpha resulted in an increased stability of GROalpha mRNA and synergistic release of GROalpha protein. Anti-IL-17 Ab blocked the effects of IL-17 in vitro and in vivo. IL-17 is capable of selectively recruiting neutrophils into the peritoneal cavity via the release of neutrophil-specific chemokines from the peritoneal mesothelium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Chemokine CXCL1
  • Chemokines, CXC / metabolism*
  • Chemotactic Factors / biosynthesis
  • Chemotactic Factors / genetics
  • Chemotactic Factors / immunology
  • Chemotactic Factors / metabolism*
  • Cycloheximide / pharmacology
  • Dactinomycin / pharmacology
  • Epithelium / immunology
  • Epithelium / metabolism
  • Growth Substances / biosynthesis
  • Growth Substances / genetics
  • Growth Substances / immunology
  • Growth Substances / metabolism*
  • Humans
  • Immune Sera / administration & dosage
  • Injections, Intraperitoneal
  • Intercellular Signaling Peptides and Proteins*
  • Interleukin-17 / administration & dosage
  • Interleukin-17 / antagonists & inhibitors
  • Interleukin-17 / immunology
  • Interleukin-17 / physiology*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Neutrophil Infiltration / immunology*
  • Peritoneum / cytology*
  • Peritoneum / immunology*
  • Peritoneum / metabolism
  • Protein Biosynthesis / drug effects
  • Protein Biosynthesis / immunology
  • RNA, Messenger / metabolism
  • Receptors, Interleukin / biosynthesis
  • Receptors, Interleukin-17
  • Recombinant Proteins / biosynthesis
  • Transcription, Genetic / drug effects
  • Transcription, Genetic / immunology
  • Tumor Necrosis Factor-alpha / physiology

Substances

  • CXCL1 protein, human
  • Chemokine CXCL1
  • Chemokines, CXC
  • Chemotactic Factors
  • Cxcl1 protein, mouse
  • Growth Substances
  • IL17RA protein, human
  • Il17ra protein, mouse
  • Immune Sera
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-17
  • RNA, Messenger
  • Receptors, Interleukin
  • Receptors, Interleukin-17
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Dactinomycin
  • Cycloheximide